GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

Home・Akcijų sąrašas・Vivesto AB

Vivesto AB

Uždarymo kaina

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-1.9M -9.1M
Pelnas, tenkantis vienai akcijai	-0.015
Darbuotojai	4
EBITDA	-1.8M -8.9M

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-1.9M 49M
Ankstesnė atidarymo kaina	0
Ankstesnė uždarymo kaina	0

Vivesto AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-16 21:37; UTC

Įsigijimai, susijungimai, perėmimai

Lensar and Alcon Agree to Terminate Merger

2026-03-16 19:06; UTC

Svarbiausios naujienos

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

2026-03-16 17:44; UTC

Įsigijimai, susijungimai, perėmimai

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

2026-03-16 23:46; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-16 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise After Oil Prices Decline -- Market Talk

2026-03-16 23:37; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2026-03-16 23:05; UTC

Rinkos pokalbiai

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

2026-03-16 21:56; UTC

Rinkos pokalbiai

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

2026-03-16 21:41; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-16 21:41; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

2026-03-16 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

2026-03-16 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

2026-03-16 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

2026-03-16 20:57; UTC

Įsigijimai, susijungimai, perėmimai

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

2026-03-16 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

2026-03-16 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-16 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

2026-03-16 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-03-16 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-16 19:53; UTC

Svarbiausios naujienos

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

2026-03-16 19:43; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-16 19:43; UTC

Rinkos pokalbiai

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

2026-03-16 19:37; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Natural Gas Follows Oil Prices Lower -- Market Talk

2026-03-16 19:20; UTC

Svarbiausios naujienos

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

2026-03-16 19:17; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

2026-03-16 19:00; UTC

Rinkos pokalbiai

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

2026-03-16 18:23; UTC

Rinkos pokalbiai

LME Restarts Trading After Outage -- Market Talk

2026-03-16 17:36; UTC

Svarbiausios naujienos

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

2026-03-16 17:19; UTC

Rinkos pokalbiai

Grains Sink as Investors Steer Toward Equities -- Market Talk

2026-03-16 17:14; UTC

Svarbiausios naujienos

Trump Ends News Conference

Akcijų palyginimas

Kainos pokytis

Vivesto AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.